BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 33735220)

  • 1. A comprehensive clinical and laboratory evaluation of 224 patients with persistent symptoms attributed to presumed tick-bite exposure.
    Nilsson K; Skoog E; Jones V; Labbé Sandelin L; Björling C; Fridenström E; Edvinsson M; Mårtensson A; Olsen B
    PLoS One; 2021; 16(3):e0247384. PubMed ID: 33735220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein biomarker profiles in serum and CSF in 158 patients with PTLDS or persistent symptoms after presumed tick-bite exposure compared to those in patients with confirmed acute neuroborreliosis.
    Nilsson K; Skoog E; Edvinsson M; Mårtensson A; Olsen B
    PLoS One; 2022; 17(11):e0276407. PubMed ID: 36327322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skin Changes in Suspected Lyme Disease.
    Vržogić P; Perica A
    Acta Dermatovenerol Croat; 2023 Dec; 31(4):225-228. PubMed ID: 38651851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular Detection of Tick-Borne Pathogens in Humans with Tick Bites and Erythema Migrans, in the Netherlands.
    Jahfari S; Hofhuis A; Fonville M; van der Giessen J; van Pelt W; Sprong H
    PLoS Negl Trop Dis; 2016 Oct; 10(10):e0005042. PubMed ID: 27706159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Classification of patients referred under suspicion of tick-borne diseases, Copenhagen, Denmark.
    Gynthersen RMM; Tetens MM; Ørbæk M; Haahr R; Fana V; Hansen K; Mens H; Andersen ÅB; Lebech AM
    Ticks Tick Borne Dis; 2021 Jan; 12(1):101591. PubMed ID: 33126203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Somatic symptoms and fatigue in a Norwegian population with high exposure to ticks.
    Thortveit ET; Lorentzen ÅR; Ljøstad U; Mygland Å
    Ticks Tick Borne Dis; 2019 Jan; 10(1):156-161. PubMed ID: 30337264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and determinants of persistent symptoms after treatment for Lyme borreliosis: study protocol for an observational, prospective cohort study (LymeProspect).
    Vrijmoeth HD; Ursinus J; Harms MG; Zomer TP; Gauw SA; Tulen AD; Kremer K; Sprong H; Knoop H; Vermeeren YM; van Kooten B; Joosten LAB; Kullberg BJ; Hovius JWR; van den Wijngaard CC
    BMC Infect Dis; 2019 Apr; 19(1):324. PubMed ID: 30987580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Lyme borreliosis. A tick bite and its multiple sequelae].
    MMW Fortschr Med; 2013 Aug; 155(14):17. PubMed ID: 24006580
    [No Abstract]   [Full Text] [Related]  

  • 9. Procalcitonin levels in patients with Lyme borreliosis.
    Lotric-Furlan S; Maraspin-Carman V; Cimperman J; Ogrinc K; Stopar T; Strle F
    Wien Klin Wochenschr; 2002 Jul; 114(13-14):530-2. PubMed ID: 12422595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of tick-borne encephalitis and Lyme borreliosis in a defined Swedish population.
    Gustafson R; Svenungsson B; Gardulf A; Stiernstedt G; Forsgren M
    Scand J Infect Dis; 1990; 22(3):297-306. PubMed ID: 2371545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of erythema migrans in spite of treatment with antibiotics after a tick bite.
    Maraspin V; Lotric-Furlan S; Strle F
    Wien Klin Wochenschr; 2002 Jul; 114(13-14):616-9. PubMed ID: 12422612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Tick borne zoonosis: selected clinical and diagnostic aspects].
    Sambri V; Marangoni A; Storni E; Cavrini F; Moroni A; Sparacino M; Cevenini R
    Parassitologia; 2004 Jun; 46(1-2):109-13. PubMed ID: 15305697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Multilocular erythema migrans in borreliosis].
    Krischer S; Ott H; Barker M; Frank J; Erdmann S
    Klin Padiatr; 2004; 216(4):236-7. PubMed ID: 15284948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythema chronicum migrans Afzelius and acrodermatitis chronica atrophicans. Early and late manifestations of Ixodes ricinus-borne Borrelia spirochetes.
    Asbrink E
    Acta Derm Venereol Suppl (Stockh); 1985; 118():1-63. PubMed ID: 3901647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lyme disease in the United Kingdom.
    Dubrey SW; Bhatia A; Woodham S; Rakowicz W
    Postgrad Med J; 2014 Jan; 90(1059):33-42. PubMed ID: 24198341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-specific symptoms and post-treatment Lyme disease syndrome in patients with Lyme borreliosis: a prospective cohort study in Belgium (2016-2020).
    Geebelen L; Lernout T; Devleesschauwer B; Kabamba-Mukadi B; Saegeman V; Belkhir L; De Munter P; Dubois B; Westhovens R; ; Van Oyen H; Speybroeck N; Tersago K
    BMC Infect Dis; 2022 Sep; 22(1):756. PubMed ID: 36171561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human granulocytic ehrlichiosis as a common cause of tick-associated fever in Southeast Sweden: report from a prospective clinical study.
    Bjöersdorff A; Wittesjö B; Berglun J; Massung RF; Eliasson I
    Scand J Infect Dis; 2002; 34(3):187-91. PubMed ID: 12030391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Not All Erythema Migrans Lesions Are Lyme Disease.
    Goddard J
    Am J Med; 2017 Feb; 130(2):231-233. PubMed ID: 27612442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Guideline 'Lyme borreliosis'].
    Speelman P; de Jongh BM; Wolfs TF; Wittenberg J;
    Ned Tijdschr Geneeskd; 2004 Apr; 148(14):659-63. PubMed ID: 15106316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bartonella spp. seroprevalence in tick-exposed Swedish patients with persistent symptoms.
    Edvinsson M; Norlander C; Nilsson K; Mårtensson A; Skoog E; Olsen B
    Parasit Vectors; 2021 Oct; 14(1):530. PubMed ID: 34641972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.